Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Outline
- What are the unmet needs in TB therapy?
- TB is a global disease
- TB is a multidimensional problem
- Current TB therapies - active TB
- Current TB therapies - latent TB
- Unmet needs in TB therapy
- Desired regimen profiles
- The approaches in TB drug development
- Process for TB drug development
- Conventional approach 1
- Conventional approach 2
- Conventional approach: issues
- New approach
- Process for novel regimen development
- New approach: advantages and challenges
- How to identify novel TB regimens
- Drug classes available for regimen development
- Drug to regimen
- Mouse infection model
- PaMZ - bactericidal activity in mouse model
- PaMZ - sterilizing activity in mouse model
- PaMZ - combination EBA design (NC-001)
- PaMZ - combination EBA results (NC-001)
- Summary
- Thank you!
Topics Covered
- Current therapies against tuberculosis and unmet needs
- Desired profile for new TB drug regimen
- Current approaches in TB drug development
- New approaches in TB regimen development
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Ma, Z. (2013, February 28). Development of new regimens for tuberculosis [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 30, 2024, from https://doi.org/10.69645/JTZF3192.Export Citation (RIS)
Publication History
Financial Disclosures
- Dr. Zhenkun Ma has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.